Stock News

Love Hemp Group PLC Announces Trading Update
aTyr Pharma Announces Last Patient Visit in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary Sarcoidosis
aTyr Pharma Inc. (LIFE): Are Hedge Funds Right About This Stock?
Love Hemp Group PLC Announces Total Voting Rights
aTyr Pharma to Host Virtual Key Opinion Leader Event on Current Treatment Options for Pulmonary Sarcoidosis
Love Hemp Group PLC Announces Endorsement Agreement Secured with Anthony Joshua
aTyr Pharma Presents Poster Demonstrating Functional Selectivity of Second Anti-NRP2 Antibody
Love Hemp Group PLC Announces Issue of Warrants and Issue of Equity
aTyr Pharma: A Penny Stock With Triple-Digit Upside
aTyr Pharma Strengthens Board of Directors with Appointment of Dr. Sara Zaknoen
aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory Effects of ATYR2810
aTyr Pharma Announces First Quarter 2021 Results and Provides Corporate Update
aTyr Pharma, Inc. to Host Earnings Call
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Achieve Milestones for First Year of Government Grant to Develop Bispecific Antibody Platform
aTyr Pharma Announces Promotion of Leslie Nangle, Ph.D., to Vice President of Research
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2021 Financial Results
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Steroids and Sarcoidosis

As seen on...